Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of Intestinal Diseases
2017-07-01
|
Series: | Intestinal Research |
Online Access: | https://doi.org/10.5217/ir.2017.15.3.263 |
id |
doaj-45e2099c0a194d0bbe4e41caa70ae9cc |
---|---|
record_format |
Article |
spelling |
doaj-45e2099c0a194d0bbe4e41caa70ae9cc2020-11-24T23:20:35ZengKorean Association for the Study of Intestinal DiseasesIntestinal Research1598-91002017-07-0115326326510.5217/ir.2017.15.3.263ir.2017.15.3.263Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?Jihye Park0Jae Hee Cheon1Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.https://doi.org/10.5217/ir.2017.15.3.263 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jihye Park Jae Hee Cheon |
spellingShingle |
Jihye Park Jae Hee Cheon Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? Intestinal Research |
author_facet |
Jihye Park Jae Hee Cheon |
author_sort |
Jihye Park |
title |
Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? |
title_short |
Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? |
title_full |
Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? |
title_fullStr |
Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? |
title_full_unstemmed |
Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? |
title_sort |
could adalimumab be used safely and effectively in intestinal behçet's disease refractory to conventional therapy? |
publisher |
Korean Association for the Study of Intestinal Diseases |
series |
Intestinal Research |
issn |
1598-9100 |
publishDate |
2017-07-01 |
url |
https://doi.org/10.5217/ir.2017.15.3.263 |
work_keys_str_mv |
AT jihyepark couldadalimumabbeusedsafelyandeffectivelyinintestinalbehcetsdiseaserefractorytoconventionaltherapy AT jaeheecheon couldadalimumabbeusedsafelyandeffectivelyinintestinalbehcetsdiseaserefractorytoconventionaltherapy |
_version_ |
1725574430103437312 |